DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 117 filers reported holding DYNE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.10 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,370,232 | -13.2% | 1,938,642 | +8.9% | 0.00% | 0.0% |
| Q2 2023 | $20,022,075 | +189.3% | 1,779,740 | +196.2% | 0.00% | – |
| Q1 2023 | $6,921,354 | -48.2% | 600,812 | -47.9% | 0.00% | – |
| Q4 2022 | $13,354,994 | +81.7% | 1,152,286 | +99.1% | 0.00% | – |
| Q3 2022 | $7,352,000 | +91.2% | 578,880 | +3.4% | 0.00% | – |
| Q2 2022 | $3,845,000 | -20.4% | 559,688 | +11.7% | 0.00% | – |
| Q1 2022 | $4,829,000 | -17.5% | 500,971 | +1.8% | 0.00% | – |
| Q4 2021 | $5,854,000 | -25.6% | 492,353 | +1.6% | 0.00% | – |
| Q3 2021 | $7,873,000 | -18.5% | 484,760 | +5.6% | 0.00% | -100.0% |
| Q2 2021 | $9,655,000 | +173.4% | 458,896 | +101.8% | 0.00% | – |
| Q1 2021 | $3,532,000 | -24.2% | 227,404 | +2.4% | 0.00% | – |
| Q4 2020 | $4,662,000 | – | 222,004 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,220,034 | $25,730,194 | 34.58% |
| MPM ASSET MANAGEMENT LLC | 4,951,303 | $57,385,602 | 24.01% |
| Atlas Venture Life Science Advisors, LLC | 9,869,483 | $114,387,308 | 13.78% |
| Logos Global Management LP | 2,150,000 | $24,918,500 | 2.92% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 641,068 | $7,417,157 | 2.29% |
| Deep Track Capital, LP | 2,684,200 | $31,109,878 | 1.31% |
| EcoR1 Capital, LLC | 2,322,384 | $26,916,431 | 0.82% |
| Vivo Capital, LLC | 577,642 | $6,695 | 0.77% |
| HighVista Strategies LLC | 102,431 | $1,187,175 | 0.70% |
| Monashee Investment Management LLC | 123,719 | $1,433,903 | 0.62% |